Breast Cancer: FDA Clears Breast Cancer Specific Molecular Prognostic Test

Breast Cancer: FDA Clears Breast Cancer Specific Molecular Prognostic Test: "The U.S. Food and Drug Administration (FDA) today cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity"